Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
Provided By GlobeNewswire
Last update: Mar 3, 2025
Total Revenue of $71.3 million for FY2024, growing 45% over FY2023;
Gross margins of 78% for FY2024, up 5% points over FY2023;
Read more at globenewswire.com
